China Resources Jiangzhong Pharmaceutical Co.,Ltd (SHA:600750)
China flag China · Delayed Price · Currency is CNY
23.21
0.00 (0.00%)
Nov 6, 2026, 3:00 PM CST

SHA:600750 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
283.27709.061,0071,3331,3711,046
Short-Term Investments
-1,233----
Trading Asset Securities
422.5495.110.0150.021,3731,728
Cash & Short-Term Investments
705.812,0381,0171,3832,7442,774
Cash Growth
-66.53%100.28%-26.43%-49.60%-1.07%33.30%
Accounts Receivable
546.55851.49940.69637.79775.45793.54
Other Receivables
18.7526.1116.2964.8743.2648.05
Receivables
565.29877.6956.99702.66818.71841.6
Inventory
444.48454.08460.97487.86386.9377.99
Prepaid Expenses
-----3.88
Other Current Assets
984.5859.1652.2753.08104.6467.24
Total Current Assets
2,7003,4282,4882,6274,0544,064
Property, Plant & Equipment
1,9551,8881,7141,6321,5201,220
Long-Term Investments
128.36930.431,7281,597174.94158.76
Goodwill
52.3752.3741.7441.7441.7441.74
Other Intangible Assets
411.33424.03397.29408.87379.07395.55
Long-Term Deferred Tax Assets
70.8961.0169.2961.1544.4544.9
Long-Term Deferred Charges
25.256.44.064.662.322.77
Other Long-Term Assets
1,29090.6865.9329.0559.0268.97
Total Assets
6,6336,8816,5086,4016,2765,998

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
793.67437.52162.75197.1236.81205.72
Accrued Expenses
67.7850.95983.21856.31813.14692.73
Short-Term Debt
4.21-----
Current Portion of Leases
1.451.440.461.251.991.7
Current Income Taxes Payable
69.6644.0857.5848.0919.7712.63
Current Unearned Revenue
81.06192.36288.48293.44358.66299.95
Other Current Liabilities
825.49379.27278.71305.91247.33103.83
Total Current Liabilities
1,8431,9061,7711,7021,6781,317
Long-Term Debt
3.57-----
Long-Term Leases
0.811.170.111.051.182.79
Long-Term Unearned Revenue
95.6183.3790.3349.6167.8573.04
Long-Term Deferred Tax Liabilities
28.1630.8317.8920.1221.5922.72
Other Long-Term Liabilities
156.79156.79156.79---
Total Liabilities
2,1282,1782,0361,7731,7681,415

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
635.59634.95629.02629.36629.58630
Additional Paid-In Capital
486.38471.29383.02469.65427.35407.82
Retained Earnings
2,7413,0012,8562,8272,8783,008
Treasury Stock
-92.65-84.63-5.72-16.42-31.5-43.28
Total Common Equity
3,7714,0233,8633,9103,9044,003
Minority Interest
734.34680.29608.83718.76604.41579.45
Shareholders' Equity
4,5054,7034,4724,6294,5084,582
Total Liabilities & Equity
6,6336,8816,5086,4016,2765,998

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
10.052.610.562.33.164.49
Net Cash (Debt)
695.762,0351,0171,3812,7412,769
Net Cash Growth
-66.96%100.13%-26.35%-49.63%-1.02%33.08%
Net Cash Per Share
1.103.211.611.924.354.38
Filing Date Shares Outstanding
629.75637.71636.1984.26625.4623.7
Total Common Shares Outstanding
629.75637.71636.1984.26625.4623.7
Working Capital
856.921,523716.43924.442,3772,748
Book Value Per Share
5.996.316.073.976.246.42
Tangible Book Value
3,3073,5463,4243,4593,4833,566
Tangible Book Value Per Share
5.255.565.383.515.575.72
Buildings
-1,6421,5571,5151,0831,059
Machinery
-1,2111,1331,030879.7796.66
Construction In Progress
-208.1599.3170.9445.67190.77